temozolomide has been researched along with glycolipids in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armando, AM; Bi, J; Cloughesy, TF; Cravatt, BF; Curtis, EJ; Furnari, FB; Gimple, RC; Gu, Y; Jing, H; Khan, A; Koga, T; Kornblum, HI; Miki, S; Mischel, PS; Prager, B; Quehenberger, O; Reed, A; Rich, JN; Rzhetsky, A; Tang, J; Wainwright, DA; Wong, IT; Wu, S; Yang, H; Zhang, W | 1 |
| Castañeda, A; Chamizo, A; Flores, MA; Garraus, M; Gorostegui, M; Lazaro, JJ; Miralles, SL; Mora, J; Muñoz, JP; Patiño, SC; Santa-Maria, V; Varo, A | 1 |
1 review(s) available for temozolomide and glycolipids
| Article | Year |
|---|---|
How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Glycolipids; Granulocyte-Macrophage Colony-Stimulating Factor; Hospitals; Humans; Irinotecan; Neuroblastoma; Spain; Temozolomide; United States | 2022 |
1 other study(ies) available for temozolomide and glycolipids
| Article | Year |
|---|---|
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Drug Repositioning; Electronic Health Records; Energy Metabolism; ErbB Receptors; Female; Fluoxetine; Glioblastoma; Humans; Mice, Nude; Permeability; Retrospective Studies; Signal Transduction; Sphingomyelin Phosphodiesterase; Sphingomyelins; Temozolomide; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |